STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
An Ohio-based DNA testing company has reported to regulators that personal information of more than 2.1 million individuals contained in a legacy database was accessed and acquired in a hacking ...
A man shows a negative COVID-19 test together with his cellphone QR code in a set up for rapid new coronavirus testing in Vienna, Austria, Monday, Nov. 30, 2020. The Austrian government has moved to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback